First National Bank of Mount Dora’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-4,002
| Closed | -$216K | – | 130 |
|
|
2025
Q4 | $216K | Buy |
+4,002
| New | +$193K | 0.05% | 118 |
|
|
2025
Q2 | – | Sell |
-4,166
| Closed | -$254K | – | 131 |
|
|
2025
Q1 | $254K | Sell |
4,166
-7
| -0.2% | -$408 | 0.06% | 118 |
|
|
2024
Q4 | $236K | Buy |
+4,173
| New | +$233K | 0.06% | 123 |
|
|
2024
Q2 | – | Sell |
-5,137
| Closed | -$279K | – | 136 |
|
|
2024
Q1 | $279K | Buy |
+5,137
| New | +$262K | 0.07% | 116 |
|
|
2023
Q3 | – | Sell |
-3,192
| Closed | -$204K | – | 135 |
|
|
2023
Q2 | $204K | Sell |
3,192
-216
| -6% | -$14.5K | 0.06% | 123 |
|
|
2023
Q1 | $236K | Sell |
3,408
-199
| -6% | -$14K | 0.07% | 115 |
|
|
2022
Q4 | $259K | Sell |
3,607
-242
| -6% | -$18.2K | 0.09% | 112 |
|
|
2022
Q3 | $273K | Sell |
3,849
-39
| -1% | -$2.83K | 0.1% | 106 |
|
|
2022
Q2 | $299K | Sell |
3,888
-60
| -2% | -$4.57K | 0.1% | 102 |
|
|
2022
Q1 | $288K | Sell |
3,948
-450
| -10% | -$30.2K | 0.09% | 108 |
|
|
2021
Q4 | $275K | Buy |
4,398
+138
| +3% | +$8.1K | 0.08% | 106 |
|
|
2021
Q3 | $252K | Hold |
4,260
| – | – | 0.08% | 103 |
|
|
2021
Q2 | $285K | Sell |
4,260
-2,010
| -32% | -$131K | 0.09% | 98 |
|
|
2021
Q1 | $395K | Hold |
6,270
| – | – | 0.14% | 88 |
|
|
2020
Q4 | $389K | Sell |
6,270
-300
| -5% | -$18.4K | 0.14% | 74 |
|
|
2020
Q3 | $396K | Buy |
6,570
+495
| +8% | +$29.8K | 0.16% | 74 |
|
|
2020
Q2 | $357K | Sell |
6,075
-150
| -2% | -$8.97K | 0.16% | 74 |
|
|
2020
Q1 | $347K | Hold |
6,225
| – | – | 0.18% | 71 |
|
|
2019
Q4 | $399K | Buy |
6,225
+125
| +2% | +$7.16K | 0.17% | 70 |
|
|
2019
Q3 | $309K | Hold |
6,100
| – | – | 0.14% | 73 |
|
|
2019
Q2 | $277K | Sell |
6,100
-800
| -12% | -$37.3K | 0.13% | 75 |
|
|
2019
Q1 | $329K | Hold |
6,900
| – | – | 0.14% | 77 |
|
|
2018
Q4 | $358K | Sell |
6,900
-138
| -2% | -$7.42K | 0.18% | 74 |
|
|
2018
Q3 | $437K | Sell |
7,038
-50
| -0.7% | -$2.97K | 0.19% | 74 |
|
|
2018
Q2 | $393K | Sell |
7,088
-300
| -4% | -$16.2K | 0.18% | 73 |
|
|
2018
Q1 | $468K | Sell |
7,388
-100
| -1% | -$6.43K | 0.22% | 72 |
|
|
2017
Q4 | $459K | Sell |
7,488
-1,300
| -15% | -$81.3K | 0.2% | 69 |
|
|
2017
Q3 | $561K | Sell |
8,788
-450
| -5% | -$26.3K | 0.28% | 60 |
|
|
2017
Q2 | $514K | Buy |
9,238
+50
| +0.5% | +$2.72K | 0.27% | 65 |
|
|
2017
Q1 | $500K | Sell |
9,188
-150
| -2% | -$8.23K | 0.27% | 62 |
|
|
2016
Q4 | $546K | Sell |
9,338
-50
| -0.5% | -$2.73K | 0.32% | 66 |
|
|
2016
Q3 | $507K | Buy |
9,388
+85
| +0.9% | +$5.46K | 0.28% | 70 |
|
|
2016
Q2 | $684K | Buy |
9,303
+775
| +9% | +$54.8K | 0.39% | 67 |
|
|
2016
Q1 | $545K | Buy |
8,528
+90
| +1% | +$5.68K | 0.32% | 68 |
|
|
2015
Q4 | $581K | Sell |
8,438
-250
| -3% | -$16.5K | 0.34% | 66 |
|
|
2015
Q3 | $514K | Sell |
8,688
-700
| -7% | -$44.4K | 0.31% | 70 |
|
|
2015
Q2 | $625K | Hold |
9,388
| – | – | 0.35% | 71 |
|
|
2015
Q1 | $605K | Hold |
9,388
| – | – | 0.33% | 70 |
|
|
2014
Q4 | $555K | Sell |
9,388
-175
| -2% | -$9.87K | 0.31% | 72 |
|
|
2014
Q3 | $489K | Hold |
9,563
| – | – | 0.29% | 73 |
|
|
2014
Q2 | $464K | Sell |
9,563
-60
| -0.6% | -$2.96K | 0.27% | 76 |
|
|
2014
Q1 | $500K | Sell |
9,623
-440
| -4% | -$23.4K | 0.3% | 74 |
|
|
2013
Q4 | $535K | Sell |
10,063
-200
| -2% | -$10.2K | 0.35% | 71 |
|
|
2013
Q3 | $475K | Hold |
10,263
| – | – | 0.35% | 72 |
|
|
2013
Q2 | $459K | Buy |
+10,263
| New | +$446K | 0.34% | 69 |
|
Other funds holding BMY
VCM
VPM
First National Bank of Mount Dora's BMY Position: Q1 2026 in Review
First National Bank of Mount Dora sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 4,002 shares — an estimated $216K sold.
First National Bank of Mount Dora first reported a position in BMY in Q2 2013 and held it in 45 quarters. The position peaked at $684K in Q2 2016. 2,526 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- First National Bank of Mount Dora reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
- First National Bank of Mount Dora sold 4,002 Bristol-Myers Squibb shares in Q1 2026, an estimated $216K.
- First National Bank of Mount Dora first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 45 quarters.
- First National Bank of Mount Dora's Bristol-Myers Squibb position peaked at $684K in Q2 2016.
- 2,526 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on First National Bank of Mount Dora's 13F filing for Q1 2026, filed 8 Jun 2026.